Lung cancer : journal of the International Association for the Study of Lung Cancer
-
Comparative Study
Pronostic factors of synchronous brain metastases from lung cancer.
The prognosis of brain metastases (BM) from lung cancer is poor. The management of lung cancer with BM is not clear. This retrospective study attempts to determine their prognostic factors, and to better define the role of different treatments. ⋯ These results and others suggest that patients with SBM from lung cancer be considered for carcinologic treatment, and not only for best supportive care. However, further studies are necessary to evaluate quality of life with or without carcinologic treatment.